Clinical Trials Browser

Phase 2 × NIH × epratuzumab × Clear all

NCT00042913 2013-12-19

Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma

Phase 2 Unknown

Lymphoma, Lymphoma, Large B-Cell, Diffuse